J. Caen

发表

Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia.

C. Soria, P. Giral, E. Bruckert, 1989, Atherosclerosis.

New carbohydrate site in mutant antithrombin (7 Ile→Asn) with decreased heparin affinity

J. Soria, C. Soria, R. Carrell, 1988, FEBS letters.

Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant

J. Gris, J. Wautier, G. Tobelem, 1992, American journal of hematology.

Effect of Lupus Anticoagulant on Antithrombogenic Properties of Endothelial Cells - Inhibition of Thrombomodulin-Dependent Protein C Activation

J. Soria, C. Soria, J. Maclouf, 1988, Thrombosis and Haemostasis.

Aprotinin Could Promote Arterial Thrombosis in Pigs: a Prospective Randomized, Blind Study

C. Samama, M. Bonneau, P. Bruneval, 1994, Thrombosis and Haemostasis.

Hemostasis in Patients Undergoing Extracorporeal Circulation: The Effect of Aprotinin (Trasylol)

J. Soria, C. Soria, He Lu, 1991, Thrombosis and Haemostasis.

ANTENATAL DIAGNOSIS OF THROMBOPATHY

Y. Gruel, F. Daffos, F. Forestier, 1987, Thrombosis and Haemostasis.

IMMUNOLOGICAL STUDY OF GLYCOPROTEINS AND ANTIGENS IN GLANZMANN'S THROMBASTHENIA HETEROZYGOTES

Y. Gruel, J. Wautier, J. Caen, 1987, Thrombosis and Haemostasis.

Membrane glycoprotein IIb is the major endogenous acceptor for human platelet ectosialyltransferase

B. Bauvois, J. Montreuil, A. Nurden, 1981, FEBS letters.

Platelet-Vessel Wall Interaction: from the Bedside to Molecules

J. Rosa, J. Caen, J. Caen, 1995, Thrombosis and Haemostasis.

Protein Tyrosine Phosphatase SHP-1 Fails to Associate with Cytoskeleton but is Normally Phosphorylated upon Thrombin Stimulation of Thrombasthenic Platelets

J. Maclouf, F. Gaits, H. Chap, 1997, Thrombosis and Haemostasis.

Detection of an Acquired Platelet Storage Pool Disease in Three Patients with a Myeloproliferative Disorder

A. Nurden, M. Lebret, F. Rendu, 1979, Thrombosis and Haemostasis.

Role of Active Center and Lysine Binding Sites of Plasmin in Plasmin-Induced Platelet Activation and Disaggregation

Hong Li, J. Soria, C. Soria, 1991, Thrombosis and Haemostasis.

KRDS, a Peptide Derived from Human Lactotransferrin, Inhibits Thrombin-Induced Thromboxane Synthesis by a Cyclooxygenase-Independent Mechanism

J. Maclouf, F. Grelac, S. Levy‐toledano, 1995, Thrombosis and Haemostasis.

Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response.

C. Demerens, M. Souyri, J. Caen, 2001, Blood.

Monoclonal Antibody to Human Platelet Glycoprotein I I. IMMUNOLOGICAL STUDIES

A. McMichael, D. Mason, G. Tobelem, 1981, British journal of haematology.

Glanzmann's thrombasthenia: the spectrum of clinical disease.

J. George, A. Nurden, J P Caen, 1990, Blood.

Monoclonal Antibody to Human Platelet Glycoprotein I II. EFFECTS ON HUMAN PLATELET FUNCTION

A. McMichael, N. Kieffer, L. Drouet, 1981, British journal of haematology.

New approach to determination of specific functions of platelet membrane sites

A. Nurden, L. Degos, G. Tobelem, 1976, Nature.

Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents.

Z. Han, J. Caen, N. Schlegel, 1997, Blood.

Platelet function, factor VIII, fibrinogen, and fibrinolysis in Nigerians and Europeans in relation to atheroma and thrombosis

A. Fleming, E. Dupuy, J. Caen, 1978, Journal of clinical pathology.

Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action.

A. Bikfalvi, X. Canron, J. Caen, 1999, Blood.

Determination of platelet antigens and glycoproteins in the human fetus.

Y. Gruel, F. Daffos, F. Forestier, 1986, Blood.

Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood.

P. Stiuso, G. Colonna, B. Di Micco, 2000, European journal of pharmacology.

Regulation of Megakaryocytopoiesis

S. Bellucci, J. Caen, M. Alemany, 1999, Pathophysiology of Haemostasis and Thrombosis.

Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin.

J. Launay, G. Simonneau, P. Hervé, 1990, The American journal of medicine.

Binding and endocytosis of heparin by human endothelial cells in culture.

M. Petitou, G. Tobelem, J. Caen, 1985, Biochimica et biophysica acta.

Hageman factor, platelets and polyphosphates: early history and recent connection

Qingyu Wu, J. Caen, J. Caen, 2010, Journal of thrombosis and haemostasis : JTH.

Availability of Platelet Factor 3 and Activation of Factor XII in Thrombasthenia

J. Caen, P. Castaldi, J. Caen, 1965, Nature.

Glanzmann's thrombasthenia: the spectrum of clinical disease.

J. George, A. Nurden, J. Caen, 1990, Blood.

Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin.

Y. Gruel, G. Pacouret, S. Bellucci, 1997, Blood.

Transfusion Studies in von Willebrand's Disease: Effect on Bleeding Time and Factor VIII

J. Caen, P. Cornu, J. Bernard, 1963, British journal of haematology.

Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease (report of thirty-seven patients).

Y. Sultan, D. Meyer, J. Caen, 1968, The American journal of medicine.

Guinea pig blood: a model for the pharmacologic modulation of the GPIb/IX-vWF axis.

A. Uzan, L. Drouet, C. Bal dit Sollier, 1996, Thrombosis research.

Clinical manifestations and erythrocyte adhesion to endothelium in sickle cell syndrome

J. Rosa, Y. Beuzard, F. Galactéros, 1985, American journal of hematology.